HK Stock MarketDetailed Quotes

06078 HYGEIA HEALTH

Watchlist
  • 36.250
  • -0.750-2.03%
Market Closed May 3 16:09 CST
22.89BMarket Cap30.39P/E (TTM)

About HYGEIA HEALTH Company

As a medical group with oncology as its core, we are committed to making medical care warmer to meet the unmet needs of Chinese cancer patients. Since starting business in 2009, we have established hospitals covering the whole country with oncology as the core through endogenous growth and strategic acquisitions. As of the date of this annual report, we manage or operate 16 hospitals with oncology as the core, spread across 13 cities in eight provinces in China. We believe that our nationwide business coverage allows us to benefit from network effects and synergy effects and achieve economies of scale, laying a solid foundation for our sustainable profitable growth and future expansion into new geographical markets. We are committed to providing one-stop comprehensive treatment services for cancer patients in non-first-tier cities. There is a large gap in cancer care services in China. Among them, the demand for cancer treatment in non-first-tier cities in China is huge, but high-quality oncology medical resources are mainly concentrated in first-tier cities. We believe that with strict quality control, high level of diagnosis and treatment technology, and caring diagnosis and treatment services, we can provide services to more cancer patients. We insist on developing one-stop comprehensive cancer diagnosis and treatment services, and develop multidisciplinary medical services around the core business of oncology. Specifically, we provide various oncology medical services including radiotherapy, chemotherapy, surgery, and targeting, gradually covering all stages of cancer diagnosis, treatment and rehabilitation, to provide cancer patients with diagnosis and treatment services throughout the life cycle. We are expanding our national network through standardized management models and matrix-like management systems. Standardized management models support endogenous growth, and hospitals are fast from construction to operation to profit. The standardized management model also supports epitaxial growth, and the Group's strong integration capabilities have led to rapid growth in performance. We are committed to developing a highly qualified, multi-disciplinary team of healthcare professionals. We continue to enrich our team through internal training and external recruitment.

Company Profile

Symbol06078
Company NameHYGEIA HEALTH
ISINKYG4712E1035
Listing DateJun 29, 2020
Issue Price18.50
Shares Offered120.00M share(s)
FoundedSep 12, 2018
Registered AddressCayman Islands
Chairmanyiwen zhu
Secretaryailiuguoxian ren
Audit InstitutionPricewaterhouseCoopers
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficeHarneys Fiduciary (Cayman) Limited 4th Floor, Harbour Place 103 South Church Street P.O. Box 10240 Grand Cayman KY1-1002 Cayman Islands
Head Office and Principal Place of Business40th Floor, Dah Sing Financial Centre, 248 Queen's Road East, Wan Chai, Hong Kong
Fiscal Year Ends12-31
Employees8238
MarketHong Kong motherboard
EmailIR@hygeia-group.com.cn
Business Hygia Medical Holdings Co., Ltd. is a Chinese investment holding company mainly engaged in oncology care business. Through its subsidiaries, the company mainly operates three business segments. The hospital business unit provides outpatient and inpatient services to patients through its own hospitals. The Radiation Therapy Business Division provides radiotherapy center consulting services, as well as the rental, sale, disposal, and after-sales repair and maintenance services of radiotherapy equipment. The hospital trusteeship business unit provides management-related services to other hospitals. The company operates in the domestic market.

Company Executives

  • Name
  • Position
  • Salary
  • yiwen zhu
  • CEOs,presidencies,Executive Director
  • --
  • huanhuan cheng
  • Co-CEO,Executive Director
  • --
  • ai ren
  • senior vice president,Assistant to the Chairman of the Board,Executive Director,Joint Company Secretary,Remuneration Committee Members,Nomination Committee Members,Authorized Representative
  • --
  • wenshan zhang
  • Director of R&D and Manufacturing,Executive Director
  • --
  • hui jiang
  • Director of Radiation Therapy,Executive Director
  • --
  • yanqun liu
  • Independent Non-Executive Director,Chairman of the Nomination Committee,Remuneration Committee Members,Audit Committee Members
  • --
  • zhangqing ye
  • Independent Non-Executive Director,Chairman of the Audit Committee
  • --
  • xue yu
  • chief financial officer
  • --
  • guoxian liu
  • Joint Company Secretary,Authorized Representative
  • --
  • chun zhao
  • Independent Non-Executive Director,Remuneration Committee Chairman,Audit Committee Members,Nomination Committee Members
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg